DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05496595 · TERMINATED
Trial details
- NCT number
- NCT05496595
- Sponsor
- DynamiCure Biotechnology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2024-02-05
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.